BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22481454)

  • 1. High coffee intake is associated with lower grade nonalcoholic fatty liver disease: the role of peripheral antioxidant activity.
    Gutiérrez-Grobe Y; Chávez-Tapia N; Sánchez-Valle V; Gavilanes-Espinar JG; Ponciano-Rodríguez G; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2012; 11(3):350-5. PubMed ID: 22481454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity.
    Georgoulis M; Fragopoulou E; Kontogianni MD; Margariti A; Boulamatsi O; Detopoulou P; Tiniakos D; Zafiropoulou R; Papatheodoridis G
    Nutr Res; 2015 Jan; 35(1):41-8. PubMed ID: 25530013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic Fatty liver disease.
    Yesilova Z; Yaman H; Oktenli C; Ozcan A; Uygun A; Cakir E; Sanisoglu SY; Erdil A; Ates Y; Aslan M; Musabak U; Erbil MK; Karaeren N; Dagalp K
    Am J Gastroenterol; 2005 Apr; 100(4):850-5. PubMed ID: 15784031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD).
    Madan K; Bhardwaj P; Thareja S; Gupta SD; Saraya A
    J Clin Gastroenterol; 2006; 40(10):930-5. PubMed ID: 17063114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of lipid peroxidation and antioxidant capacity in non-alcoholic fatty liver disease.
    Sariçam T; Kircali B; Köken T
    Turk J Gastroenterol; 2005 Jun; 16(2):65-70. PubMed ID: 16252194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High dietary salt decreases antioxidant defenses in the liver of fructose-fed insulin-resistant rats.
    Dornas WC; de Lima WG; dos Santos RC; Guerra JF; de Souza MO; Silva M; Souza e Silva L; Diniz MF; Silva ME
    J Nutr Biochem; 2013 Dec; 24(12):2016-22. PubMed ID: 24135554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Status of antioxidant and lipid peroxidation in type 2 diabetic human subjects diagnosed with and without metabolic syndrome by using NCEP-ATPIII, IDF and WHO criteria.
    Yadav D; Mishra M; Joseph AZ; Subramani SK; Mahajan S; Singh N; Bisen PS; Prasad GB
    Obes Res Clin Pract; 2015; 9(2):158-67. PubMed ID: 25890429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.
    Polyzos SA; Kountouras J; Papatheodorou A; Katsiki E; Patsiaoura K; Zafeiriadou E; Papadopoulou E; Zavos C; Terpos E
    Ann Hepatol; 2013; 12(5):749-57. PubMed ID: 24067262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative Stress and Nonalcoholic Fatty Liver Disease in Hemodialysis Patients.
    Wu PJ; Chen JB; Lee WC; Ng HY; Lien SC; Tsai PY; Wu CH; Lee CT; Chiou TT
    Biomed Res Int; 2018; 2018():3961748. PubMed ID: 30515395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different grape formulations on antioxidative capacity, lipid peroxidation and oxidative DNA damage in aged rats.
    Rho KA; Kim MK
    J Nutr Sci Vitaminol (Tokyo); 2006 Feb; 52(1):33-46. PubMed ID: 16637228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of nonalcoholic fatty liver disease with insulin resistance.
    Marchesini G; Brizi M; Morselli-Labate AM; Bianchi G; Bugianesi E; McCullough AJ; Forlani G; Melchionda N
    Am J Med; 1999 Nov; 107(5):450-5. PubMed ID: 10569299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between insulin resistance, metabolic syndrome and nonalcoholic fatty liver disease in non-obese non-diabetic Turkish individuals: A pilot study.
    Erkan G; Sayın I; Polat FB; Çorakçı A; Ataç GK; Değertekin H
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():63-8. PubMed ID: 25910371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Condition of lipid peroxidation and antioxidant system in patients with non-alcoholic fatty liver disease].
    Fillipova OIu
    Lik Sprava; 2013; (7):36-43. PubMed ID: 25509913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coffee Intake and Liver Steatosis: A Population Study in a Mediterranean Area.
    Veronese N; Notarnicola M; Cisternino AM; Reddavide R; Inguaggiato R; Guerra V; Rotolo O; Zinzi I; Leandro G; Correale M; Tutino V; Misciagna G; Osella AR; Bonfiglio C; Giannelli G; Caruso MG;
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29342916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls.
    Da Silva HE; Arendt BM; Noureldin SA; Therapondos G; Guindi M; Allard JP
    J Acad Nutr Diet; 2014 Aug; 114(8):1181-94. PubMed ID: 24631112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and nonalcoholic fatty liver disease. The role of endothelial progenitor cells.
    Gutiérrez-Grobe Y; Gavilanes-Espinar JG; Masso-Rojas FA; Sánchez-Valle V; Páez-Arenas A; Ponciano-Rodríguez G; Chávez-Tapia NC; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2013; 12(6):908-14. PubMed ID: 24114821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic fatty liver disease in overweight children and its relationship with retinol serum levels.
    Suano de Souza FI; Silverio Amancio OM; Saccardo Sarni RO; Sacchi Pitta T; Fernandes AP; Affonso Fonseca FL; Hix S; Ramalho RA
    Int J Vitam Nutr Res; 2008 Jan; 78(1):27-32. PubMed ID: 18654951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coffee consumption and nonalcoholic fatty liver onset: a prospective study in the general population.
    Zelber-Sagi S; Salomone F; Webb M; Lotan R; Yeshua H; Halpern Z; Santo E; Oren R; Shibolet O
    Transl Res; 2015 Mar; 165(3):428-36. PubMed ID: 25468486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
    Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonalcoholic steatohepatitis in morbid obese patients: coffee consumption vs. disease severity.
    Barros RK; Cotrim HP; Daltro C; Alves E; de Freitas LA; Daltro C; Oliveira Y
    Ann Hepatol; 2016; 15(3):350-5. PubMed ID: 27049488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.